Pharmacist Portal Dispense an ePrescription
Vivus, the biopharmaceutical company behind investigational drugs Qnexa and Avanafil, has just reported its financial results for the first nine months of 2010...
The FDA (Food and Drug Administration) has rejected Qnexa, the third weight loss drug in as many weeks that did not meet the requirements of the FDA...
Vivus, the California based biopharmaceutical company today announced the results of a two-year study of Qnexa...
Following on from our news on Reductil yesterday, we have now heard that the FDA Advisory Panel has recommended against approving Lorcaserin as a weight loss drug in the USA...
We have more news on the drug companies that continually endeavour to find an effective weight loss pill to beat the international problem of obesity...